Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
Video Forum: Christine Baeder, Teva USA
Latest
Retail sales rise in November as holiday spending stays on track with NRF's forecast
"Retail sales showed healthy year-over-year gains in November while month-over-month data was largely flat,”
Costco delivers strong first quarter, fueled by membership growth and E-commerce surge
Comparable sales climbed 6.4%, topping analysts’ expectations of 5.8%.
CRN praises FDA for clarifying DSHEA disclaimers’ placement
The Council for Responsible Nutrition commended the FDA for clarifying how companies can place the Dietary Supplement Health and Education Act disclaimer on labels.
Uber deepens regional grocery footprint with three new retailers
New partnerships highlight Uber’s growing investment in beloved local and regional retailers.